NLRP3 and Cognitive impairment: Treatment with A. muciniphila reduced regulated cognitive impairment and hippocampal NLRP3-mediated neuroinflammation through improving intestinal barrier function and attenuating Th17 responses in the gut, central nervous system, and lymphoid tissues of mice (Li et al., 2025).